ARTICLE | Clinical News
ATX-F8-117 regulatory update
December 22, 2014 8:00 AM UTC
The European Commission granted Orphan Drug designation to ATX-F8-117 from Apitope to treat hemophilia A. The combination of 2 peptides derived from Factor VIII is in preclinical testing to treat and ...